A quality assurance audit: phase III trial of maximal androgen deprivation in prostate cancer (TROG 96.01).
Steigler A, Mameghan H, Lamb D, Joseph D, Matthews J, Franklin I, Turner S, Spry N, Poulsen M, North J, Kovacev O, Denham J.
Steigler A, et al. Among authors: denham j.
Australas Radiol. 2000 Feb;44(1):65-71. doi: 10.1046/j.1440-1673.2000.00774.x.
Australas Radiol. 2000.
PMID: 10761262
Clinical Trial.